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ABSTRACT
In mammalian genomes a sixth base,
5-hydroxymethylcytosine (
hmC), is generated by en-
zymatic oxidation of 5-methylcytosine (
mC). This dis-
covery has raised fundamental questions about the
functional relevance of
hmC in mammalian genomes.
Due to their very similar chemical structure, discrim-
ination of the rare
hmC against the far more
abundant
mC is technically challenging and to date
no methods for direct sequencing of
hmC have been
reported. Here, we report on a purified recombinant
endonuclease, PvuRts1I, which selectively cleaves
hmC-containing sequences. We determined the
consensus cleavage site of PvuRts1I as
hmCN11–12/
N9–10G and show first data on its potential to inter-
rogate
hmC patterns in mammalian genomes.
INTRODUCTION
In higher eukaryotes, only the C5 position of genomic
cytosine is subject to enzymatically catalyzed
post-replicative modiﬁcation. Methylation at this
position has long been known to play major roles in epi-
genetic control of transcriptional activity and, as a conse-
quence, to affect fundamental processes such as
development (including natural reprogramming of cell
fate), imprinting, X chromosome inactivation, genome
stability and predisposition to neoplastic transformation
(1,2). The recent discovery of the further modiﬁcation of
5–methylcytosine (
mC) to 5-hydroxymethylcytosine (
hmC)
by the family of Tet dioxygenases has raised major ques-
tions on the functional relevance of this sixth base in
mammalian genomes (3,4). While recent evidence
supports a role for
hmC as an intermediate in the erasure
of cytosine methylation (5), other roles in controlling
genomic functions cannot be excluded. The deﬁnition of
these roles will require proﬁling of genomic
hmC patterns,
which presents a major technical challenge as
hmC is struc-
turally and chemically very similar to
mC but in general far
less abundant in mammalian genomes (3,4,6–9). The gold
standard methodology for proﬁling of genomic
mC sites,
bisulﬁte conversion, cannot discriminate
hmC from
mC
and all available restriction endonucleases are either
equally sensitive to
mC and
hmC or not sensitive to
either (10–12). While antibodies raised against
hmC are
commercially available, their use to probe
hmC frequency
by DNA immunoprecipitation has yet to be reported and
the accuracy of this method will depend on the relative
afﬁnity of these antibodies for
hmC versus
mC as the latter
is present in large excess in mammalian genomes. Very
recently enzymatic methods for selective labeling and
identiﬁcation of
hmC have been reported (7,13).
Interestingly,
hmC is also present in the genomes of
viruses that infect bacteria and unicellular algae, where
it serves as protection against the restriction systems of
the host. In particular,
hmC accounts for up to 100% of
the cytosine residues in the genomes of T-even coliphages.
In these phages the hydroxymethyl group is added at the
level of the dCMP precursor and further linked to glucose
(in both a- and b-conﬁgurations) or gentiobiose after in-
corporation of the nucleotide in the genome (14–16). We
sought to exploit enzymatic activities that evolved as part
of the struggle between bacteria and these viruses to se-
lectively detect
hmC in mammalian genomes. Recently, we
described an assay for quantiﬁcation of global genomic
hmC levels based on the transfer of tritiated glucose to
hmCb yT 4b-glucosyltransferase (7). Interestingly, restric-
tion systems have evolved in bacteria that address the
phage counter defense measures by speciﬁcally recognizing
modiﬁed cytosine. Among these the McrBC system and
the recently described MspJI endonuclease recognize se-
quences containing both
mC and
hmC (17,18) and
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modiﬁed cytosines. At least two endonucleases,
PvuRts1I and GmrSD, were shown to restrict DNA con-
taining glucosylated
hmC (19,20). However, GmrSD does
not cleave non-glucosylated (
hmC-containing) T4 DNA,
has the additional disadvantages of being a heterodimer
and of co-purifying with the GroEL chaperonin (19).
PvuRts1I is encoded by a single gene present on the kana-
mycin resistance plasmid Rts1 originally isolated from
Proteus vulgaris and its restriction activity in vivo was
shown to be modulated by
hmC glucosylation in a
complex fashion (20). However, as PvuRts1I was not
puriﬁed, its activity has not been characterized in vitro.
Here, we show that puriﬁed recombinant PvuRts1I se-
lectively cleaves
hmC-containing DNA and determine its
cleavage site. In addition, we present initial data on the
use of
hmC as a tool to investigate
hmC patterns in mam-
malian genomes.
MATERIALS AND METHODS
Cloning and puriﬁcation of PvuRts1I
The sequence encoding PvuRts1I was synthesized at Mr
Gene GmbH (Regensburg) and cloned into the pET28a
vector (Novagen). BL21(DE3) Escherichia coli cells
carrying the expression vector were grown in LB
medium at 37 C until A600=0.6–0.7 and induced with
1mM isopropyl b-D-thiogalactopyranoside for 16h at
18 C. Lysates were prepared by sonication in 300mM
NaCl, 50mM Na2HPO4 pH 8.0, 10mM imidazole, 10%
glycerol and 1mM b-mercaptoethanol, cleared by centri-
fugation and applied to a nickel–nitrilotriacetic acid
column (QIAGEN) pre-equilibrated with lysis buffer.
Washing and elution were performed with lysis buffer con-
taining 20 and 250mM imidazole, respectively. Eluted
proteins were applied to a Superdex S-200 preparative
gel ﬁltration column (GE Healthcare) in 150mM NaCl,
20mM Tris pH 8.0, 10% glycerol, 1mM DTT and peak
fractions were pooled. The stability of PvuRts1I upon
storage was improved by supplementation with 10%
glycerol.
Preparation of DNA substrates
In vivo a/b-glucosylated and non-glucosylated T4 phage
DNA was isolated essentially as described (4). Brieﬂy,
T4 stocks were propagated on E. coli strain CR63,
which was also used for the isolation of glucosylated T4
DNA. To isolate non-glucosylated T4 DNA, wild-type T4
phage was ampliﬁed on an ER1565 galU mutant strain.
b-glucosylated T4 DNA was generated in vitro by treat-
ment of non-glucosylated T4 DNA with puriﬁed T4
b-glucosyltransferase (7). Genomic DNA was isolated
from mouse cerebellum and triple knockout (TKO) em-
bryonic stem cells (ESCs) (21) as described (7).
Reference DNA fragments containing exclusively
hmC,
mC or unmodiﬁed cytosine residues were prepared by PCR
using 5-hydroxymethyl-dCTP (Bioline GmbH),
5-methyl-dCTP (Jena Bioscience GmbH) and dCTP, re-
spectively. T4 phage DNA template, Phusion HF DNA
Polymerase (Finnzymes) and primer 50-GTG AAG TAA
GTA ATA AAT GGA TTG-30, which does not contain
cytosine residues, were used for ampliﬁcation of all refer-
ence DNA fragments. To generate the reference 1139bp
fragment with 100%
hmC for restriction with PvuRts1I the
second primer was 50-TGG AGA AGG AGA ATG AAG
AAT AAT-30, which also does not contain cytosine
residues. To generate the 800 and 500bp control sub-
strates containing only
mC and only unmodiﬁed cytosine
for restriction with PvuRTS1I the second primer was 50-
GCC ATA TTG ATA ATG AAA TTA AAT GTA-30 and
50-TCA GCA ATT TTA ATA TTT CCA TCT TC-30,
respectively. PCR products were puriﬁed by gel electro-
phoresis followed by silica column puriﬁcation
(Nucleospin, Macherey-Nagel). The 140bp fragment
used to determine the orientation of the PvuRTS1I
cleavage overhang was ampliﬁed with primers 50-TAT
ACT GAA GTA CTT CAT CA-30 and 50-CTT TGC
GTG ATT TAT ATG TA-30.
For the preparation of substrates with a single PvuRts1I
consensus containing
hmCo r
mC in symmetrical or asym-
metrical conﬁguration a 94bp fragment was ampliﬁed
from the T4 genome with primers 50-CTC GTA GAC
TGC GTA CCA ATC TAA CTC AGG ATA GTT
GAT-30 and 50-TAT GAT AAG TAT GTA GGT TAT
T-30. This fragment contains a single site corresponding to
the identiﬁed PvuRts1I consensus
hmCN11–12/N9–10G and
was used as a template according to the strategy depicted
in Figure 3. To generate substrates with symmetric
cytosine modiﬁcations or unmodiﬁed cytosine the
fragment was ampliﬁed with forward primer 50-CTC
GTA GAC TGC GTA CCA-30 and reverse primer 1
50-TAT GAT AAG TAT GTA GGT TAT T-30 in the
presence of the respective modiﬁed or unmodiﬁed dCTP.
To generate substrates with asymmetric cytosine modiﬁ-
cations the same forward primer was paired with reverse
primer 2 50-TAT GAT AAG TAT GTA GGT TAT TCA
A-30.
DNA restriction with PvuRts1I and identiﬁcation of
cleavage and recognition site
Unless otherwise stated the reaction conditions contained
150mM NaCl, 20mM Tris pH 8.0, 5mM MgCl2,1 m M
DTT. One unit of PvuRTS1I was deﬁned as amount of
enzyme required to digest 1mgo f
hmC-containing T4 DNA
in 15min at 22 C. For assessment of enzyme speciﬁcity,
100ng of each control fragment were digested separately
or together with 200ng of genomic DNA in 30ml reactions
containing standard buffer and 1U of puriﬁed PvuRts1I
at 22 C for 15min.
For identiﬁcation of the cleavage and recognition site,
the 1139bp fully hydroxymethylated fragment ampliﬁed
from the T4 genome or whole non-glucosylated T4
DNA were digested under standard conditions.
Fragment ends were blunted with Klenow polymerase
(NEB) and cloned using the Zero Blunt PCR Cloning
Kit (Invitrogen). Randomly selected clones were
sequenced and the data were analyzed using
WebLogo (22).
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hmC-speciﬁc endonuclease activity of PvuRts1I
His-tagged PvuRts1I was expressed in E. coli and puriﬁed
to homogeneity by sequential Ni
2+ afﬁnity and size exclu-
sion chromatography (Figure 1A). As bacteria carrying
the Rts1 plasmid were shown to restrict the
hmC-containing T-even phages, but not
mC-containing
T-odd phages or  phage, which does not contain
modiﬁed cytosine (20), we initially used T4 genomic
DNA as a substrate to test the activity of puriﬁed
PvuRts1I. T4 genomic DNA was isolated from both
galU
+ and galU
  strains, the latter being UDP-glucose
deﬁcient and thus containing only non-glucosylated
hmC.
Under the same digestion conditions non-glucosylated T4
DNA was digested more efﬁciently than both naturally a-
and b-glucosylated and in vitro b-glucosylated counter-
parts (Figure 1B). Non-glucosylated T4 DNA was
cleaved into fragments with an apparent size of about
200bp, indicating that PvuRts1I recognizes a frequently
occurring sequence (Figure 1B and Supplementary
Figures S1 and S2). We then used non-glucosylated T4
DNA to test the activity of the enzyme under various con-
ditions. PvuRts1I was strictly dependant on Mg
2+ ions,
which could not be substituted with Ca
2+, and endonucle-
ase activity was maximal in the presence of 100–200mM
NaCl (Supplementary Figure S1A and B). However,
during puriﬁcation we observed that the enzyme is
unstable in solutions of ionic strength lower than
150mM NaCl. The activity of PvuRts1I was found
highest at pH 7.5–8.0 and was unaffected by the
presence of Tween 20 or Triton X-100 (Supplementary
Figure S2A and B). We also observed that after prolonged
incubation PvuRts1I precipitates even at room tempera-
ture, consistent with the reported temperature sensitivity
of the phage restriction activity in cells carrying the Rts1
plasmid (20). Upon short incubation times maximal
activity was observed at 22 C (Supplementary Figure
2C). Thus, the relative amounts of enzyme and DNA sub-
strate were standardized so that digestion was complete in
15min at 22 C in the presence of 150mM NaCl
(Supplementary Figures S1C and S2C).
The speciﬁcity of PvuRts1I with respect to cytosine
modiﬁcation was further tested by digesting reference
fragments containing exclusively unmodiﬁed cytosine
(500bp),
mC (800bp) or
hmC (1139bp; Figure 1C).
Under standard digestion conditions puriﬁed PvuRts1I
selectively cleaved the
hmC-containing fragment, consist-
ent with the relative restriction efﬁciency of bacterio-
phages with distinct cytosine modiﬁcations by bacteria
carrying the Rts1 plasmid (20).
Determination of PvuRts1I cleavage sites
To identify the cleavage pattern of PvuRts1I we generated
libraries of restriction fragments from either the whole T4
genome (Supplementary Figure S3) or an 1139bp
fragment ampliﬁed from the same genome containing ex-
clusively hydroxymethylated cytosines (Figure 2).
Random sequencing of 161 and 133 fragment ends from
the whole T4 genome and 1139bp fragment libraries
revealed that 85 and 89%, respectively, matched the con-
sensus sequence
hmCN11–12/N9–10G. Among these 78 and
87%, respectively, showed one of three similar sequence
patterns,
hmCN12/N10G,
hmCN12/N9G and
hmCN11/N9G,
while for the remaining fragment ends the exact number of
nucleotides between the modiﬁed cytosine and the
cleavage site could not be determined unambiguously
due to the occurrence of multiple
hmC residues upstream
of the cleavage site. Of the sequenced fragment ends, 14
and 11% from the whole T4 genome and 1139bp
fragment libraries, respectively, did not match the
hmCN11–12/N9–10G consensus. However, 100 and 80% of
these ends, respectively, contained at least one
hmC residue
10–13nt upstream of the cleavage site, while no guanine
was present in the T4 genomic sequence 10–11nt down-
stream the cleavage site (Supplementary Figure S4). The
sequenced clones from the 1139bp T4 genomic fragment
library corresponded to an 81% coverage of the fragment,
with some PvuRts1I fragments occurring multiple times,
while other fragments that were predicted on the basis of
the
hmCN11–12/N9–10G consensus were not found (Figure 2
and Supplementary Figure S5). Examination of the
missing fragments did not show any common sequence
feature beyond the
hmCN11–12/N9–10G consensus
(Supplementary Figure S6), suggesting that their absence
from the sequenced fragments was due to limited
sampling. Alignment of sequenced fragment ends from
the T4 genomic fragment library showed that 2nt
around the cleavage site were missing from all clones, sug-
gesting a 2nt 30-overhang cleavage pattern
Figure 1. Selective restriction of
hmC-containing DNA by PvuRts1I. (A) Puriﬁed PvuRts1I was resolved on a SDS–polyacrylamide gel and stained
with coomassie blue. (B) T4 genomic DNA with the naturally occurring pattern of a- and b-glucosylated
hmC, only b-glucosylated
hmCo r
non-glucosylated
hmC was incubated without or with decreasing amounts of PvuRts1I as indicated. (C) Reference PCR fragments of 1139, 800
and 500bp containing
hmC,
mC and unmodiﬁed cytosine at all cytosine residues, respectively, were incubated with or without PvuRTS1I as indicated.
Nucleic Acids Research, 2011,Vol.39, No. 12 5151(Supplementary Figure S5). This was conﬁrmed by direct
sequencing of the two fragments generated by digestion of
a 140bp amplicon containing a single PvuRts1I site
(Supplementary Figure S7).
The results above reveal a symmetric nature of the
preferred cleavage sites and raise the issue of PvuRTs1I
activity on sites with modiﬁed cytosine in symmetric and
asymmetric conﬁguration. To clarify this issue, we used a
PCR strategy to generate DNA substrates with identical
sequence and containing a single PvuRts1I consensus site
with
hmCo r
mC in symmetrical and asymmetrical conﬁg-
urations or no modiﬁed cytosine (Figure 3A). In the
presence of enzyme amounts that did not cleave substrates
with unmodiﬁed and
mC sites, digestion of substrates with
asymmetric
hmC at the PvuRTs1I site was reduced with
respect to substrates with symmetric
hmC, but still appre-
ciable. Residual undigested substrate with symmetric
hmC
at the PvuRTs1I site in these reaction conditions was typ-
ically observed with such short substrates, but not with
longer ones.
Digestion of mammalian genomic DNA with PvuRts1I
To investigate cleavage site preference and efﬁciency of
PvuRts1I digestion for mammalian genomic DNA, we
initially selected the upstream regulatory region III of
the mouse nanog gene (23). As this region was shown to
be bound by Tet1 and to acquire CpG methylation upon
knockdown of Tet1 in ESCs (5), it represents a potential
candidate as a mammalian genomic sequence containing
hmC. Real time ampliﬁcation of this region from ESC
genomic DNA did not show a signiﬁcant decrease of
product after PvuRts1I digestion (data not shown). We
then devised a strategy to positively identify rare
PvuRts1I digestion products. After PvuRts1I digestion
genomic fragments were ligated to a linker with a
random 2nt 30-overhang. Ligation products were then
ampliﬁed using nanog speciﬁc primers paired with a
linker speciﬁc primer, but no ampliﬁcation product
could be obtained (data not shown). This result may be
explained by an extremely seldom occurrence of
hmCa t
Figure 2. Cleavage site of PvuRts1I. A library of PvuRts1I restriction fragments was generated from an 1139bp PCR fragment containing only
hydroxymethylated cytosine residues and the sequence of 133 restriction fragment ends from randomly chosen clones was determined. (A) Graphical
map of the fragment ends. A total of 119 analyzed fragment ends (triangles) matched the consensus sequence
hmCN11–12/N9–10G, which was present
at 97 sites (thin vertical lines) in the 1139bp PCR fragment (thick horizontal line). Fifty three fragment ends related to the sequence motif
hmCN12/
N10G (dark green triangles), 37 to
hmCN11/N10G (bright green triangles) and 14 to
hmCN11/N9G (light green triangles), while 15 fragment ends
matching the consensus sequence
hmCN11–12/N9–10G could not assigned unambiguously to any of these subsets (gray triangles). Fourteen fragment
ends did not match the prevalent consensus sequence (gray circles, see Supplementary Figure S3). (B) Occurrence of the three subsets of cleavage sites
and LOGO representation of the corresponding consensus sequence. The absolute height of each position reﬂects its overall conservation, while the
relative height of nucleotide letters represents their relative frequency. The slash in the three cleavage sequence subtypes indicates the exact cleavage
site.
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uration), inefﬁciency of PvuRts1I digestion or both. In
this regard, it is important to consider that positive iden-
tiﬁcation of
hmC sites in this region of the nanog locus has
actually not been reported for ESCs. In addition, during
the revision of the present work a manuscript was pub-
lished (24) that could not conﬁrm the reduced nanog ex-
pression and ESC differentiation previously reported
upon Tet1 knockdown (5), raising uncertainty about the
actual occurrence of
hmC at the nanog promoter in ESCs.
As there are no clear and quantitative data on the levels
and density of
hmC at speciﬁc genomic sites available yet
we generated deﬁned substrates to validate the PvuRst1I
cut-ligation ampliﬁcation protocol for the identiﬁcation of
hmC sites. We PCR ampliﬁed region III of the nanog
promoter in the presence of increasing concentrations of
5-hydroxymethyl-dCTP and conﬁrmed the incorporation
of proportional levels of
hmC using the recently reported
b-glucosylation assay (7) (data not shown). Fragment
samples with increasing
hmC content were then digested
with PvuRts1I and the same ligation/PCR strategy for the
identiﬁcation of digestion products was applied as
described above (Supplementary Figure S8A). Detection
of fragments with ends corresponding to the PvuRts1I
cleavage pattern raised with increasing
hmC content.
We previously quantiﬁed global
hmC levels in genomic
DNA from ESCs and adult somatic tissues using in vitro
hmC glucosylation (7). Consistent with other studies
(3,6,8,9), this analysis revealed that genomic DNA from
adult brain regions has a high
hmC content. In addition,
we showed that in ESCs that are TKO for all three major
DNA methyltransferases Dnmt1, 3a and 3b (21) genomic
hmC levels were around the estimated limit of detection,
although reproducibly above background. Therefore, we
compared the PvuRts1I restriction pattern of genomic
DNA from cerebellum and TKO ESCs as representative
of samples with high and very low
hmC levels, respectively.
As internal controls, we co-digested each of the two
genomic DNA samples with the same reference fragments
as used to test the speciﬁcity of PvuRts1I with respect to
cytosine modiﬁcation (Figure 1C). As expected from the
relative low abundance of
hmC in mammalian genomic
DNA, there was a limited reduction of high molecular
weight fragments and appearance of lower molecular
weight smear (Figure 4). However, DNA from cerebellum
was clearly digested to a higher extent than DNA from
TKO ESCs as evident from the line scans across the re-
spective gel lanes (Figure 4). The low but appreciable
degree of digestion observed for genomic DNA from
TKO ESCs does not seem to result from relaxed speciﬁcity
or contaminating nuclease activities, as only control sub-
strates containing
hmC, but not
mC or unmodiﬁed
cytosine, were digested when incubated either separately
or together with genomic DNA (Figure 1C and Figure 4).
Figure 3. Differential activity of PvuRts1I on sites with symmetric and asymmetric
hmC. Ninety-four bp long substrates with identical sequence were
generated that contain a single PvuRts1I consensus site (CN12/N10G) with
hmCo r
mC in symmetrical and asymmetrical conﬁgurations or no modiﬁed
cytosine. (A) Strategy for generation of the substrates by PCR ampliﬁcation in the presence of modiﬁed nucleotides. The size of the PvuRts1I
digestion products is indicated. (B) The variously modiﬁed substrates were digested with the indicated amounts of PvuRts1I and digestion products
were resolved on polyacrylamide gels. Note the reduced but tangible digestion of the substrate containing asymmetric
hmC.
Nucleic Acids Research, 2011,Vol.39, No. 12 5153Absence of digestion of control substrates containing
mC
and unmodiﬁed cytosine was evident from the unaltered
ratio of their respective signals in the presence and absence
of enzyme. This result shows that the extent of digestion
by PvuRts1I reﬂects the relative
hmC content in mamma-
lian genomic DNA.
DISCUSSION
Several modiﬁcation and restriction systems have evolved
as defense and counter defense strategies in the struggle
between unicellular microorganisms and their viruses.
Here, we show that, in contrast to previously
characterized endonucleases which cleave
hmC-containing
sequences, PvuRts1I has a preference for the
non-glucosylated form of this base and discriminates
against
mC. This speciﬁcity makes PvuRts1I an attractive
tool to investigate genomic
hmC patterns in higher eukary-
otes and complements the very recently published
methods for enzymatic labeling of this sixth base (7,13).
Importantly, we show that the extent of PvuRts1I di-
gestion reﬂects the relative abundance of
hmC in genomic
DNA from cerebellum and TKO ESCs. The limited extent
of digestion even for samples with relatively high
hmC
content is in line with the cleavage site preference and
dependence on cytosine modiﬁcation that we determined.
We calculate that the statistical probability of the
PvuRts1I consensus site CN11–12/N9–10G in the mouse
genome is 0.126. Combined with the global
hmC occur-
rence in mouse tissues (up to 0.13% of all bases or
0.65% of Cs) (3,7–9) this translates into a PvuRts1I
cleavage site every 1.9 10
5 bases. As this is in the size
range of fragments typically obtained with standard pro-
cedures for isolation of genomic DNA, more careful iso-
lation methods should be used and/or PvuRts1I speciﬁc
ends could be enriched by ligating biotinylated PvuRts1I
compatible linkers. Alternatively, digestion conditions
could be optimized or DNA could be denatured and a
second strand synthesized with
hmC nucleotides to cut
and reveal the likely more abundant hemimodiﬁed
PvuRts1I sites.
Notably, while cerebellum has been previously reported
among the tissues with the highest levels of genomic
hmC
(3,7,9), complete absence of
mC and therefore
hmC would
be expected in TKO ESCs due to the lack of all three
major Dnmts (21). However, we previously detected
hmC
levels slightly above background in TKO ESCs (7) and
here we show minimal but appreciable digestion by
PvuRts1I. In this context, it is interesting to note that
ESCs express the highly conserved Dnmt2 (25,26), the
only Dnmt family member with an intact catalytic
domain that has not been genetically inactivated in TKO
ESCs. Although Dnmt2 has a major role as a tRNA
methyltransferase and its function as a DNA
methyltransferase is still debated (27–32), it was recently
shown to methylate genomic sequences in Drosophila
(32,33). Future work should clarify whether the genome
of TKO ESCs harbors any residual
mC and
hmC.
Restriction of genomic DNA with PvuRts1I may be
combined with PCR ampliﬁcation for analysis of speciﬁc
loci or with massive parallel sequencing or microarray hy-
bridization for genome-wide mapping. The calculations
reported above for the frequency of PvuRts1I cleavage
sites based on a random
hmC distribution bring up the
argument that the extent of random breaks in genomic
DNA preparations would contribute very signiﬁcant
noise in deep sequencing and microarray applications.
This drawback may at least be partially overcome if
speciﬁc PvuRts1I ends are enriched by ligating linkers
with a random 2nt 30-overhang as described here and dis-
cussed above, a strategy that can be integrated with pro-
cedures for generation of sequencing libraries. Also, our
simulation of genomic fragments containing known levels
of randomly distributed
hmC clearly shows that relatively
high local concentrations of
hmC sites are required for ef-
ﬁcient detection by PvuRts1I. The ﬁrst genome-wide
hmC
TKO ESCs
++
PvuRts1I
--
+ PvuRts1I
PvuRts1I _
hmC
mC
C
gray values (x1000)
hmC
mC
C
Cerebellum
gray values (x1000)
05 10 15 20 25 30 0 5 10 15 20 25 30
+ PvuRts1I
PvuRts1I _
Figure 4. Restriction of mouse genomic DNA by PvuRts1I reﬂects
hmC content. Genomic DNA from mouse cerebellum or TKO ESCs was mixed
with three reference PCR fragments of 1139, 800 and 500bp containing
hmC,
mC and unmodiﬁed cytosine at all cytosine residues, respectively, and
incubated with or without PvuRts1I as indicated. Digests were resolved on a 0.8% agarose gel stained with ethidium bromide. Line scans of the gel
lanes are aligned to the image of the gel. Red and blue lines correspond to samples incubated with and without enzyme, respectively. Arrows point to
the main difference in the proﬁles form cerebellum and TKO ESC DNA digested with PvuRts1I (red lines).
5154 Nucleic Acids Research, 2011,Vol.39, No. 12proﬁles from mammalian tissues have just been reported
(13). From these ﬁrst data sets, it is apparent that genomic
hmC is not randomly distributed and that its accumulation
in gene bodies is proportional to transcriptional activity.
Thus, PvuRts1I may prove a valuable tool to probe
hmC
accumulation at deﬁned genomic regions. In addition, the
selectivity of PvuRts1I for
hmC-containing sites may con-
stitute an advantage with respect to endonucleases such as
McrBC and MspJ1 as these enzymes do not discriminate
between
mC and
hmC and require in vitro enzymatic
hmC
glucosylation to speciﬁcally protect
hmC-containing sites
from digestion and thus distinguish them from
mC sites.
In conclusion, we show that PvuRts1I is an
hmC speciﬁc
endonuclease and provide a biochemical characterization
of its enzymatic properties for future applications as diag-
nostic tool in the analysis of
hmC distribution at genomic
loci in development and disease.
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